EDSA
Edesa Biotech Inc
NASDAQ: EDSA · HEALTHCARE · BIOTECHNOLOGY
$18.28
+14.94% today
Updated 2026-04-30
Market cap
$64.51M
P/E ratio
—
P/S ratio
130,462.29x
EPS (TTM)
$-1.07
Dividend yield
—
52W range
$1 – $12
Volume
5.6M
Edesa Biotech Inc (EDSA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $854837.00 | $697187.00 | $286054.00 | $545469.00 | $372132.00 | $758689.00 | $1.27M | $228287.00 | $211849.00 | $410870.00 | $328801.00 | $500.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | -18.4% | -59.0% | +90.7% | -31.8% | +103.9% | +67.6% | -82.0% | -7.2% | +93.9% | -20.0% | -99.8% | -100.0% | — | — | — |
| Cost of revenue | — | $386088.00 | $1.01M | $436401.00 | $576528.00 | $760259.00 | $840247.00 | $1.13M | $534453.00 | $445320.00 | $101286.00 | $17601.00 | $118788.00 | $118188.00 | $183471.00 | $186049.00 | $119273.00 |
| Gross profit | — | $468749.00 | $-311896.00 | $-150347.00 | $-31059.00 | $-388127.00 | $-81558.00 | $143861.00 | $-306166.00 | $-233471.00 | $309584.00 | $311200.00 | $-118788.00 | $-118188.00 | $-183471.00 | $-186049.00 | $-119273.00 |
| Gross margin | — | 54.8% | -44.7% | -52.6% | -5.7% | -104.3% | -10.7% | 11.3% | -134.1% | -110.2% | 75.3% | 94.6% | -23757.6% | — | — | — | — |
| R&D | — | $352780.00 | $906518.00 | $1.83M | $1.45M | $2.46M | $1.03M | $1.73M | $1.97M | $2.09M | $1.10M | $3.33M | $17.95M | $13.34M | $4.79M | $2.88M | $3.67M |
| SG&A | $78499.00 | $1.15M | $5.84M | $4.43M | $2.24M | $2.87M | $3.23M | $3.32M | $2.94M | $2.76M | $2.05M | $3.38M | $5.73M | $5.04M | $4.43M | $4.13M | $4.24M |
| Operating income | $-78557.00 | $-1.07M | $-7.10M | $-6.52M | $-3.68M | $-5.72M | $-4.34M | $-4.91M | $-5.22M | $-5.08M | $-2.83M | $-6.40M | $-23.68M | $-18.37M | $-9.22M | $-7.01M | $-7.91M |
| Operating margin | — | -124.6% | -1018.4% | -2280.2% | -674.4% | -1536.7% | -571.9% | -386.0% | -2288.6% | -2397.1% | -689.3% | -1946.7% | -4736266.4% | — | — | — | — |
| EBITDA | $-64647.00 | $-761820.00 | $-3.51M | $-6.43M | $-3.72M | $-8.25M | $-2.65M | $-4.87M | $-4.85M | $-4.85M | $-2.83M | $-6.34M | $-13.22M | $-17.43M | $-9.22M | $-5.98M | $-7.07M |
| EBITDA margin | — | -89.1% | -503.3% | -2249.2% | -682.5% | -2218.0% | -348.9% | -382.9% | -2124.7% | -2289.3% | -688.1% | -1929.2% | -2644712.0% | — | — | — | — |
| EBIT | $-69345.00 | $-775093.00 | $-3.60M | $-6.55M | $-3.85M | $-8.41M | $-2.81M | $-5.02M | $-5.03M | $-5.04M | $-2.83M | $-6.40M | $-13.34M | $-17.55M | $-9.22M | $-6.17M | $-7.18M |
| Interest expense | $58.00 | $3734.00 | $11297.00 | $4881.00 | $4990.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $56840.00 | $94975.00 | $116931.00 | $822666.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-73917.00 | $-589971.00 | $-7.09M | $-5.20M | $-14.89M | $-8.44M | $-2.84M | $-5.03M | $-5.03M | $-5.04M | $-2.72M | $-6.36M | $-13.34M | $-17.55M | $-8.37M | $-6.17M | $-7.19M |
| Net income growth (YoY) | — | -698.2% | -1101.1% | +26.7% | -186.5% | +43.3% | +66.3% | -76.8% | -0.1% | -0.2% | +46.0% | -133.9% | -109.7% | -31.5% | +52.3% | +26.3% | -16.5% |
| Profit margin | — | -69.0% | -1016.4% | -1816.7% | -2729.1% | -2267.9% | -374.7% | -395.2% | -2203.7% | -2378.6% | -662.3% | -1935.6% | -2668630.0% | — | — | — | — |